Search This Blog

Monday, December 31, 2018

Mallinckrodt price target lowered to $21 from $37 at B. Riley FBR


B. Riley FBR analyst David Buck lowered his price target for Mallinckrodt to $21 after the company earlier this month announced plans to spin off a new company consisting of its specialty generics business and Amitiza to shareholders. The analyst keeps a Neutral rating on the shares.

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.